Topic: Novartis AG
ULURUInc.(NYSE Alternext: ULU)announced today that it has signed a worldwide distribution agreement appointing Novartis the exclusive distributor...
Swiss stocks erased earlier losses as drugmakers Novartis AG and Roche Holding AG advanced. . . The Swiss Market Index climbed less than 0.1...
Shares in Teva, the world's biggest generic drug company, are up 2% on news that a judge rejected a motion to declare patents on the company's...
Indresh Srivastava, Ph.D., Head of Protein Biology, Novartis, will give a featured presentation at the 5th Biological Therapeutics Research and...
Stephen Turner, Founder & Chief Technology Officer of Pacific Biosciences and Michael R. Jackson, Vice President, Drug Discovery and Development of...
Actavis in talks to buy 51 pct of Bioton's BioPartners. . * Move to give Icelandic firm platform in biosimilar drugs. . . Icelandic drugmaker ...
Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published Thursday in the journal Science.The drug could be ready for clinical trials as ...
The Swiss pharmaceutical group Novartis plans to build Latin America's first vaccine factory in Brazil with an investment of 300 to 500 million dollars, the financial daily Valor reported Thursday.The plant, which will be located near the northeastern cit
ZURICH (Reuters) - Swiss drugmaker Novartis AG is pushing ahead with its contentious buyout of Alcon minority shareholders after completing its acquisition of stock from Nestle to get control of the U.S. eyecare group.Novartis, which now holds a 77 per
Novartis completes $38.7 billion purchase of Nestle's stake in eye care firm AlconSwiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost ...